Phase I clinical trial to assess the safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN protein vaccinations and to seek the appropriate dose of the pNGVL4aCRTE6E7L2 DNA vaccine

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2024-11, Vol.190, p.S294-S294
Main Authors: Levinson, Kimberly, Arend, Rebecca, Roden, Richard, Wu, T.C., Ostrander, Darin, Horner, Karen, Swann, Sellers, Ketch, Peter, Gentry, Zachary, Harsono, Alfonsus Adrian, Oladipo, Fibiana, Clevenger, Stephanie, Wilbanks, Anna, Barton, Wade, Bos, Lia, Hung, Chien-Fu, Leath, Charles, Huh, Warner
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
DOI:10.1016/j.ygyno.2024.07.439